Genetic medicine in systems Flashcards
how do pathogenic variants cause disease? (4 different ways)
- null variants
- gain of function variants
- dominant negative variants
- loss of heterozygosity
what are null variants?
= when gene stops making peptide
- premature stop codon
- frameshift
- splice mutation
- gene deletion
e.g. marfan syndrome
what is haploinsufficiency?
haploinsufficiency = less functioning protein so cell can’t make stuff it needs
what is gain of function variants type of pathogenic variant causing disease?
= variant leads to peptide with gain of or new function
- missense variants
- activates the genes
e.g. hypochondroplasia
what is dominant negative variants?
= variant leads to peptide that interferes with another peptide
- missense variant
- makes abnormal collagen
e.g. osteogenesis imperfecta type 2
abnormal collagen messes up normal peptide
2 peptides need to work together - 1 peptide messes with the other. variant leads to peptide that interferes with another peptide
what is loss of heterozygosity?
= first null copy is inherited somatic loss of second copy
- fist null copy
inherits 1 germline variant - gets 2nd somatic variant means can no longer
second allele lost in cell
(i think it’s like the cancer - need 2 hits)
when can genetic therapy be used? at what point?
at every point in central dogma
how does treatment work for genetic diseases?
it has to be very highly specific - not just to disease but specific to the genetic variant
how do you treat null pathogenic variants?
You need to replace the gene of the mRNA (as peptide has stopped being made due to premature stop)
how do you treat gain of function or dominant negative mechanisms?
You need to reduce mutant gene expression
what are the risks of integrating gene therapy?
- Disruption of important genes (“Off Target effects”)
what is the negative of mRNA knockdown or mRNA gene replacement?
Need for repeated treatment
what are the risks for viral vectors to deliver gene therapy?
- Immune reaction to the vector
- Immune reaction to the transfected cell
what is the big negative for all the developments for genetic disease treatment?
unaffordable and unsustainable
what are precision therapies targeted at?
specific causative variant (not everyone with a disease)